TransCode Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 75.68 K | $25.64 K | -1.13% | 0.03% |
| SHEETS SMITH WEALTH MANAGEMENT | 05/26/2023 | 60.00 K | $20.31 K | 140.00% | 0.02% |
| ONE68 GLOBAL CAPITAL, LLC | 05/15/2023 | 30.12 K | $10.20 K | 100.00% | 0.01% |
| STATE STREET CORP | 05/15/2023 | 21.02 K | $7.12 K | 0.00% | 0.01% |
| WARBERG ASSET MANAGEMENT LLC | 05/15/2023 | 20.00 K | $6.77 K | 100.00% | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 19.41 K | $6.57 K | 0.00% | 0.01% |
| SHAY CAPITAL LLC | 05/15/2023 | 15.06 K | $5.10 K | 0.00% | 0.01% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 13.12 K | $4.44 K | -23.36% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 6.35 K | $2.00 K | 0.00% | 0.00% |
| BLACKROCK INC. | 05/12/2023 | 1.39 K | $469 | -91.17% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 51 | $17 | 2.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| CAHILL WEALTH MANAGEMENT, LLC | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TransCode Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of TransCode Therapeutics, Inc.. The most heavily invested institutionals were:
ACT CAPITAL MANAGEMENT, LLC: 6,500
0.09% of TransCode Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.50 K shares in the last 24 months. This purchase volume represents approximately $74.43 K in transactions.